Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease

被引:212
作者
St-Pierre, AC
Ruel, IL
Cantin, B
Dagenais, GR
Bernard, PM
Després, JP
Lamarche, B
机构
[1] CHU Laval, Lipid Res Ctr, Quebec City, PQ G1V 4G2, Canada
[2] Univ Laval, Dept Food Sci & Nutr, Quebec City, PQ G1K 7P4, Canada
[3] Laval Hosp, Quebec Heart Inst, Quebec City, PQ, Canada
[4] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada
关键词
lipids; epidemiology; lipoproteins; ischemia; heart diseases; nutrition;
D O I
10.1161/hc4401.098490
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Several cross-sectional studies and 3 prospective, nested, case-control studies have indicated that individuals with small, dense low density lipoprotein (LDL) particles are at increased risk for ischemic heart disease (IHD). However, whether LDL particle size is an independent risk factor for future IHD events remains controversial. The objective of the present study was to further analyze the cardiovascular risk associated with various electrophoretic characteristics of LDL particles in men, Methods and Results-LDL particles were characterized by polyacrylamide gradient gel electrophoresis (PAGGE) in a cohort of 2034 men of the Quebec Cardiovascular Study. All men were initially free of IHD and were followed up for a period of 5 years, during which 108 first IHD events were recorded. Among all LDL characteristics investigated by PAGGE, including LDL peak particle size, the cholesterol concentration in LDL particles with a diameter smaller than 255 Angstrom showed the strongest association with the risk of IHD (relative risk=4.6 in men in the third vs first tertile of the distribution, P <0.001). Multivariate logistic and survival models indicated that the relationship between LDL cholesterol levels in particles with a diameter < 255 Angstrom and IHD risk was independent of all nonlipid risk factors and of LDL cholesterol, high density lipoprotein cholesterol, triglyceride, and lipoprotein(a) levels. Conclusions-Results from this large, population-based, prospective study suggest that further characterization of LDL particles by PAGGE, in addition to the traditional lipid profile, may improve our ability to predict IHD events in men.
引用
收藏
页码:2295 / 2299
页数:5
相关论文
共 17 条
[1]  
[Anonymous], 1992, Current Opinion in Lipidology
[2]   Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men [J].
Austin, MA ;
Rodriguez, BL ;
McKnight, B ;
McNeely, MJ ;
Edwards, KL ;
Curb, JD ;
Sharp, DS .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (04) :412-416
[3]   METHOD FOR QUANTITATING CHOLESTEROL IN SUBFRACTIONS OF SERUM-LIPOPROTEINS SEPARATED BY GRADIENT GEL-ELECTROPHORESIS [J].
CHENG, ML ;
KAMMERER, CM ;
LOWE, WF ;
DYKE, B ;
VANDEBERG, JL .
BIOCHEMICAL GENETICS, 1988, 26 (11-12) :657-681
[4]  
DAGENAIS GR, 1990, CAN J CARDIOL, V6, P274
[5]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[6]   Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women [J].
Gardner, CD ;
Fortmann, SP ;
Krauss, RM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (11) :875-881
[7]   PREVALENCE OF RISK-FACTORS IN MEN WITH PREMATURE CORONARY-ARTERY DISEASE [J].
GENEST, JJ ;
MCNAMARA, JR ;
SALEM, DN ;
SCHAEFER, EJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (15) :1185-1189
[8]   Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men - Prospective results from the Quebec Cardiovascular Study [J].
Lamarche, B ;
Tchernof, A ;
Moorjani, S ;
Cantin, B ;
Dagenais, GR ;
Lupien, PJ ;
Despres, JP .
CIRCULATION, 1997, 95 (01) :69-75
[9]   PREVALENCE OF DYSLIPIDEMIC PHENOTYPES IN ISCHEMIC-HEART-DISEASE (PROSPECTIVE RESULTS FROM THE QUEBEC CARDIOVASCULAR STUDY) [J].
LAMARCHE, B ;
DESPRES, JP ;
MOORJANI, S ;
CANTIN, B ;
DAGENAIS, GR ;
LUPIEN, PJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (17) :1189-1195
[10]  
Lamarche B, 1999, DIABETES METAB, V25, P199